Key terms

About SGRY

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SGRY news

Mar 29 3:07am ET Surgery Partners: A Buy Rating Amidst Underperformance and Growth Potential Mar 26 8:44am ET Surgery Partners Subsidiary Announces $600M Notes Offering Mar 06 6:35am ET Barclays starts health care facilities, managed care group with Neutral view Mar 05 4:32pm ET Surgery Partners initiated with an Equal Weight at Barclays Feb 29 6:55pm ET Surgery Partners: Maintaining Buy Rating with Slight EBITDA Adjustment and Price Target Increase Feb 29 7:21am ET RBC Capital Sticks to Its Buy Rating for Surgery Partners (SGRY) Feb 28 12:06am ET Surgery Partners: Strong Q4 Performance and Growth Outlook Secure Buy Rating Feb 27 11:36pm ET Surgery Partners: A Buy Rating with Upside Potential on Strong FCF and Growth Prospects Feb 27 1:23pm ET Surgery Partners price target lowered to $42 from $43 at Citi Feb 27 8:36am ET Cantor Fitzgerald Sticks to Its Buy Rating for Surgery Partners (SGRY) Feb 27 8:10am ET Analysts Are Bullish on Top Healthcare Stocks: Bruker (BRKR), Hims & Hers Health (HIMS) Feb 27 7:11am ET Analysts’ Top Healthcare Picks: BioCryst (BCRX), Veracyte (VCYT) Feb 27 5:49am ET Surgery Partners’ Expansion and Positive Earnings Outlook Prompt ‘Buy’ Rating Feb 26 7:33am ET Surgery Partners sees 2024 revenue greater than $3B, consensus $2.99B Feb 26 7:32am ET Surgery Partners reports Q4 adjusted EPS 44c, consensus 38c Jan 26 8:47pm ET Surgery Partners (SGRY) Receives a Buy from RBC Capital Jan 11 1:26am ET Surgery Partners: Poised for Sustained Earnings Growth with an Upward EBITDA Trajectory Jan 10 7:03am ET Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), IDEAYA Biosciences (IDYA) and Surgery Partners (SGRY) Jan 08 7:33am ET Surgery Partners reaffirms FY23 revenue guidance $2.75B, consensus $2.75B

No recent news articles are available for SGRY

No recent press releases are available for SGRY

SGRY Financials

1-year income & revenue

Key terms

SGRY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SGRY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms